Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walerian Piotrowski

Showing results (11-20 of 84) with videos related to

Pageof 9
Sort By:
Kardiologia Polska|September 20, 2013
Hepatocyte growth factor - the earliest marker of myocardial injury in ST-segment elevation myocardial infarctionAnna Konopka, Jadwiga Janas, Walerian Piotrowski, et al.
Gene|April 6, 2012
Polymorphisms of angiotensin II type 1 receptor gene and those of angiotensinogen point at culprit artery in ST-segment elevation myocardial infarctionAnna Konopka, Małgorzata Szperl, Walerian Piotrowski, et al.
Kardiologia Polska|September 19, 2006
Endothelium-dependent acetylcholine-induced vasodilatory response of saphenous vein graftsAndrzej Ciszewski, Cezary Kepka, Walerian Piotrowski, et al.
Cytokine|January 15, 2013
Concentration of vascular endothelial growth factor in patients with acute coronary syndromeAnna Konopka, Jadwiga Janas, Walerian Piotrowski, et al.
Kardiologia Polska|December 25, 2012
Sudden cardiovascular death rate and ischaemic heart disease death rate changes during the 5-year period of 2003-2008Walerian Piotrowski, Maria Polakowska, Jacek Koziarek, et al.
Kardiologia Polska|November 9, 2004
Is the assessment of lipid profile performed up to seventy two hours from hospital admission due to acute coronary syndrome still valid?Anna Konopka, Ewa Chodkowska, Walerian Piotrowski, et al.
Molecular Diagnosis & Therapy|November 21, 2009
Influence of some cardiovascular risk factors on the expression of platelet glycoprotein IIb/IIIa receptors in patients with myocardial infarction treated with antiplatelet drugs under primary percutaneous coronary interventionAnna Konopka, Justyna Spychalska, Walerian Piotrowski, et al.
Growth Factors (Chur, Switzerland)|November 27, 2009
Hepatocyte growth factor--a new marker for prognosis in acute coronary syndromeAnna Konopka, Jadwiga Janas, Walerian Piotrowski, et al.
Chemosphere|January 10, 2012
Qualitative structure residue relationship analysis in the determination of the maximum residue limit of veterinary drugsTomasz Grabowski, Jerzy Jan Jaroszewski, Walerian Piotrowski, et al.
Kardiologia Polska|January 19, 2016
Prognostic significance of reactive pulmonary hypertension in patients with chronic heart failure listed for elective heart transplantationMałgorzata Sobieszczańska-Małek, Tomasz Zieliński, Walerian Piotrowski, et al.
Pageof 9

Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
Kardiologia Polska|September 20, 2013
Hepatocyte growth factor - the earliest marker of myocardial injury in ST-segment elevation myocardial infarctionAnna Konopka, Jadwiga Janas, Walerian Piotrowski, et al.
Gene|April 6, 2012
Polymorphisms of angiotensin II type 1 receptor gene and those of angiotensinogen point at culprit artery in ST-segment elevation myocardial infarctionAnna Konopka, Małgorzata Szperl, Walerian Piotrowski, et al.
Kardiologia Polska|September 19, 2006
Endothelium-dependent acetylcholine-induced vasodilatory response of saphenous vein graftsAndrzej Ciszewski, Cezary Kepka, Walerian Piotrowski, et al.
Cytokine|January 15, 2013
Concentration of vascular endothelial growth factor in patients with acute coronary syndromeAnna Konopka, Jadwiga Janas, Walerian Piotrowski, et al.
Kardiologia Polska|December 25, 2012
Sudden cardiovascular death rate and ischaemic heart disease death rate changes during the 5-year period of 2003-2008Walerian Piotrowski, Maria Polakowska, Jacek Koziarek, et al.
Kardiologia Polska|November 9, 2004
Is the assessment of lipid profile performed up to seventy two hours from hospital admission due to acute coronary syndrome still valid?Anna Konopka, Ewa Chodkowska, Walerian Piotrowski, et al.
Molecular Diagnosis & Therapy|November 21, 2009
Influence of some cardiovascular risk factors on the expression of platelet glycoprotein IIb/IIIa receptors in patients with myocardial infarction treated with antiplatelet drugs under primary percutaneous coronary interventionAnna Konopka, Justyna Spychalska, Walerian Piotrowski, et al.
Growth Factors (Chur, Switzerland)|November 27, 2009
Hepatocyte growth factor--a new marker for prognosis in acute coronary syndromeAnna Konopka, Jadwiga Janas, Walerian Piotrowski, et al.
Chemosphere|January 10, 2012
Qualitative structure residue relationship analysis in the determination of the maximum residue limit of veterinary drugsTomasz Grabowski, Jerzy Jan Jaroszewski, Walerian Piotrowski, et al.
Kardiologia Polska|January 19, 2016
Prognostic significance of reactive pulmonary hypertension in patients with chronic heart failure listed for elective heart transplantationMałgorzata Sobieszczańska-Małek, Tomasz Zieliński, Walerian Piotrowski, et al.
Pageof 9